Healthcare used to be based on science. Now it’s based on vibes

An influential doctor and pro-transgender activist withheld publication of a $10 million taxpayer-funded study on the effectiveness of puberty blockers.

For the study, researchers chose 95 gender-distressed children at an average age of 11 years old and gave them puberty-blocking drugs starting in 2015. The drugs delay the onset of puberty-driven changes such as breast development for girls and deepening of the voice for boys. The delay of the development of these sex characteristics is intended to alleviate gender dysphoria by allowing the subjects to remain less visibly “sexed.”